CUA Educational Content

The Role of ADT Across the Continuum of Prostate Cancer

EDITORTIAL COMMITTEE: Fred Saad, Gulia Delouya, Shaun Goodman, Bobby Shayegan

By participating in this program, health care providers can expect to:

  • describe the hormonal therapy continuum for prostate cancer, including the role of androgen deprivation therapy (ADT) as the backbone of therapy
  • explain the rationale for earlier treatment with hormonal therapies in patients with high-risk prostate cancer
  • discuss strategies to minimize the potential cardiovascular (CV) side effects of ADT
  • review recent advances in the treatment of advanced prostate canced


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

​This program was made possible with financial support from Tolmar.